Dr. Anna Langerveld joins Advisory Board for Manchester University’s new Pharmacogenomics Program

Genemarkers CEO Dr. Anna Langerveld recently joined the Advisory Board for the Master of Science in Pharmacogenomics Program at Manchester University. Manchester is the first university to offer a one-year Master of Science in Pharmacogenomics, an important step in this emerging field. The program prepares graduates for employment in the genetic testing and pharmaceutical industries on all aspects of pharmacogenomic testing, including sample accessioning and preparation, sample analysis, data storage, data mining and reporting, or to pursue a Ph.D. or a professional degree in fields like medicine, pharmacy or dentistry.

As a member of the Advisory Board, Dr. Langerveld will provide guidance and advising to address specific questions raised by program faculty and students and to identify the most pressing needs in PGX.

2017-05-25T18:12:52+00:00